新創建集團(00659.HK):票據要約最高接納金額修改為3億美元
格隆匯3月22日丨新創建集團(00659.HK)發佈公吿,收購要約已於2022年5月27日下午四時正屆滿。董事會因此宣佈:要約人根據收購要約的條款及條件,將最高接納金額修改為3億美元,並已接納根據經修訂荷蘭式拍賣程序釐定的有效交回票據,以本金額每1,000美元為940美元的購買價購買本金總額共為3億美元的票據。於本公吿日期,最終接納金額佔票據尚餘本金總額6.36億美元約47%;收購要約結算後,票據尚餘本金總額為3.36億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.